422 related articles for article (PubMed ID: 23642017)
1. Antifibrotic effects of focal adhesion kinase inhibitor in bleomycin-induced pulmonary fibrosis in mice.
Kinoshita K; Aono Y; Azuma M; Kishi J; Takezaki A; Kishi M; Makino H; Okazaki H; Uehara H; Izumi K; Sone S; Nishioka Y
Am J Respir Cell Mol Biol; 2013 Oct; 49(4):536-43. PubMed ID: 23642017
[TBL] [Abstract][Full Text] [Related]
2. Modulation of prosurvival signaling in fibroblasts by a protein kinase inhibitor protects against fibrotic tissue injury.
Vittal R; Horowitz JC; Moore BB; Zhang H; Martinez FJ; Toews GB; Standiford TJ; Thannickal VJ
Am J Pathol; 2005 Feb; 166(2):367-75. PubMed ID: 15681821
[TBL] [Abstract][Full Text] [Related]
3. Focal Adhesion Kinase Regulates Fibroblast Migration via Integrin beta-1 and Plays a Central Role in Fibrosis.
Zhao XK; Cheng Y; Liang Cheng M; Yu L; Mu M; Li H; Liu Y; Zhang B; Yao Y; Guo H; Wang R; Zhang Q
Sci Rep; 2016 Jan; 6():19276. PubMed ID: 26763945
[TBL] [Abstract][Full Text] [Related]
4. Antifibrotic and anti-inflammatory activity of the tyrosine kinase inhibitor nintedanib in experimental models of lung fibrosis.
Wollin L; Maillet I; Quesniaux V; Holweg A; Ryffel B
J Pharmacol Exp Ther; 2014 May; 349(2):209-20. PubMed ID: 24556663
[TBL] [Abstract][Full Text] [Related]
5. Sunitinib, a Small-Molecule Kinase Inhibitor, Attenuates Bleomycin-Induced Pulmonary Fibrosis in Mice.
Huang X; Wang W; Yuan H; Sun J; Li L; Wu X; Luo J; Gu Y
Tohoku J Exp Med; 2016 Aug; 239(4):251-61. PubMed ID: 27439438
[TBL] [Abstract][Full Text] [Related]
6. Dual tyrosine kinase inhibitor for focal adhesion kinase and insulin-like growth factor-I receptor exhibits anticancer effect in esophageal adenocarcinoma in vitro and in vivo.
Watanabe N; Takaoka M; Sakurama K; Tomono Y; Hatakeyama S; Ohmori O; Motoki T; Shirakawa Y; Yamatsuji T; Haisa M; Matsuoka J; Beer DG; Nagatsuka H; Tanaka N; Naomoto Y
Clin Cancer Res; 2008 Jul; 14(14):4631-9. PubMed ID: 18628478
[TBL] [Abstract][Full Text] [Related]
7. Homocysteine-induced myofibroblast differentiation in mouse aortic endothelial cells.
Sen U; Moshal KS; Tyagi N; Kartha GK; Tyagi SC
J Cell Physiol; 2006 Dec; 209(3):767-74. PubMed ID: 16972260
[TBL] [Abstract][Full Text] [Related]
8. Plasminogen activator inhibitor-1 promotes the proliferation and inhibits the apoptosis of pulmonary fibroblasts by Ca(2+) signaling.
Zhang YP; Wang WL; Liu J; Li WB; Bai LL; Yuan YD; Song SX
Thromb Res; 2013 Jan; 131(1):64-71. PubMed ID: 23021499
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of transforming growth factor-β via the activin receptor-like kinase-5 inhibitor attenuates pulmonary fibrosis.
Koh RY; Lim CL; Uhal BD; Abdullah M; Vidyadaran S; Ho CC; Seow HF
Mol Med Rep; 2015 May; 11(5):3808-13. PubMed ID: 25585520
[TBL] [Abstract][Full Text] [Related]
10. The D prostanoid receptor agonist BW245C [(4S)-(3-[(3R,S)-3-cyclohexyl-3-hydroxypropyl]-2,5-dioxo)-4-imidazolidineheptanoic acid] inhibits fibroblast proliferation and bleomycin-induced lung fibrosis in mice.
van den Brule S; Wallemme L; Uwambayinema F; Huaux F; Lison D
J Pharmacol Exp Ther; 2010 Nov; 335(2):472-9. PubMed ID: 20719937
[TBL] [Abstract][Full Text] [Related]
11. Prevention of bleomycin-induced pulmonary fibrosis by a novel antifibrotic peptide with relaxin-like activity.
Pini A; Shemesh R; Samuel CS; Bathgate RA; Zauberman A; Hermesh C; Wool A; Bani D; Rotman G
J Pharmacol Exp Ther; 2010 Dec; 335(3):589-99. PubMed ID: 20826567
[TBL] [Abstract][Full Text] [Related]
12. Gefitinib prevents bleomycin-induced lung fibrosis in mice.
Ishii Y; Fujimoto S; Fukuda T
Am J Respir Crit Care Med; 2006 Sep; 174(5):550-6. PubMed ID: 16741154
[TBL] [Abstract][Full Text] [Related]
13. The inhibitory effect of ginsan on TGF-β mediated fibrotic process.
Ahn JY; Kim MH; Lim MJ; Park S; Lee SL; Yun YS; Song JY
J Cell Physiol; 2011 May; 226(5):1241-7. PubMed ID: 20945375
[TBL] [Abstract][Full Text] [Related]
14. HGF reduces advancing lung fibrosis in mice: a potential role for MMP-dependent myofibroblast apoptosis.
Mizuno S; Matsumoto K; Li MY; Nakamura T
FASEB J; 2005 Apr; 19(6):580-2. PubMed ID: 15665032
[TBL] [Abstract][Full Text] [Related]
15. Oral administration of FAK inhibitor TAE226 inhibits the progression of peritoneal dissemination of colorectal cancer.
Hao HF; Takaoka M; Bao XH; Wang ZG; Tomono Y; Sakurama K; Ohara T; Fukazawa T; Yamatsuji T; Fujiwara T; Naomoto Y
Biochem Biophys Res Commun; 2012 Jul; 423(4):744-9. PubMed ID: 22705303
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory effect of l-mimosine on bleomycin-induced pulmonary fibrosis in rats: Role of eIF3a and p27.
Li XW; Hu CP; Li YJ; Gao YX; Wang XM; Yang JR
Int Immunopharmacol; 2015 Jul; 27(1):53-64. PubMed ID: 25957199
[TBL] [Abstract][Full Text] [Related]
17. Peptide-mediated inhibition of mitogen-activated protein kinase-activated protein kinase-2 ameliorates bleomycin-induced pulmonary fibrosis.
Vittal R; Fisher A; Gu H; Mickler EA; Panitch A; Lander C; Cummings OW; Sandusky GE; Wilkes DS
Am J Respir Cell Mol Biol; 2013 Jul; 49(1):47-57. PubMed ID: 23470623
[TBL] [Abstract][Full Text] [Related]
18. Effects of doxycycline on production of growth factors and matrix metalloproteinases in pulmonary fibrosis.
Fujita H; Sakamoto N; Ishimatsu Y; Kakugawa T; Hara S; Hara A; Amenomori M; Ishimoto H; Nagata T; Mukae H; Kohno S
Respiration; 2011; 81(5):420-30. PubMed ID: 21502778
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of activin receptor-like kinase 5 attenuates bleomycin-induced pulmonary fibrosis.
Higashiyama H; Yoshimoto D; Kaise T; Matsubara S; Fujiwara M; Kikkawa H; Asano S; Kinoshita M
Exp Mol Pathol; 2007 Aug; 83(1):39-46. PubMed ID: 17274978
[TBL] [Abstract][Full Text] [Related]
20. Imatinib as a novel antifibrotic agent in bleomycin-induced pulmonary fibrosis in mice.
Aono Y; Nishioka Y; Inayama M; Ugai M; Kishi J; Uehara H; Izumi K; Sone S
Am J Respir Crit Care Med; 2005 Jun; 171(11):1279-85. PubMed ID: 15735062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
